Biocorp
Designs and manufactures connected drug delivery systems and smart devices for pharma.
ALCOR | PA
Overview
Corporate Details
- ISIN(s):
- FR0012788065
- LEI:
- 969500TKUAME6031UQ32
- Country:
- France
- Address:
- PARC INDUSTRIEL TECH LAVAUR LA BECHADE, 63500 ISSOIRE
- Website:
- https://biocorpsys.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Biocorp designs, develops, and manufactures innovative medical devices and drug delivery systems for the pharmaceutical industry. The company specializes in both connected and non-connected devices, with expertise in creating proprietary connected systems and smart add-on solutions for existing parenteral and respiratory drug delivery platforms. Its product portfolio includes devices like Mallya, a smart sensor for injection pens that helps monitor and manage chronic diseases. Founded in 2004, Biocorp was acquired by Novo Nordisk in 2023.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Biocorp and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-01-25 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 135.9 KB | |
| 2024-01-25 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 158.2 KB | |
| 2023-10-03 10:59 |
Major Shareholding Notification
Franchissement de seuils
|
French | 202.6 KB | |
| 2023-10-02 17:30 |
Share Issue/Capital Change
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 116.9 KB | |
| 2023-10-02 14:04 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 146.3 KB | |
| 2023-09-06 11:20 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 136.6 KB | |
| 2023-09-04 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 306.3 KB | |
| 2023-09-04 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 325.3 KB | |
| 2023-08-28 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuil
|
French | 201.1 KB | |
| 2023-08-28 13:57 |
Major Shareholding Notification
Franchissement de seuils
|
French | 203.1 KB | |
| 2023-08-07 14:00 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 390.4 KB | |
| 2023-08-04 18:00 |
M&A Activity
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 160.8 KB | |
| 2023-08-04 18:00 |
M&A Activity
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 165.6 KB | |
| 2023-08-02 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 140.7 KB | |
| 2023-07-06 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 140.7 KB |
Automate Your Workflow. Get a real-time feed of all Biocorp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Biocorp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-14 | N/A | Other | Other | 30,000 | 1,050,000.00 EUR |
| 2023-09-14 | N/A | Other | Other | 7,450 | 260,750.00 EUR |
| 2023-09-14 | N/A | Other | Other | 6,000 | 210,000.00 EUR |
| 2023-08-04 | N/A | Other | Sell | 1,998,800 | 69,958,000.00 EUR |
